BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lau WY. Future perspectives for hepatocellular carcinoma. HPB (Oxford) 2003;5:206-13. [PMID: 18332989 DOI: 10.1080/13651820310016779] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Sonoda A, Nitta N, Ohta S, Nitta-Seko A, Nagatani Y, Takahashi M, Murata K. Enhanced antitumor effect of tirapazamine delivered intraperitoneally to VX2 liver tumor-bearing rabbits subjected to transarterial hepatic embolization. Cardiovasc Intervent Radiol 2011;34:1272-7. [PMID: 21479745 DOI: 10.1007/s00270-011-0156-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2 Wu CC, Cheng SB, Ho WM, Chen JT, Liu TJ, P'eng FK. Liver resection for hepatocellular carcinoma in patients with cirrhosis. Br J Surg. 2005;92:348-355. [PMID: 15672423 DOI: 10.1002/bjs.4838] [Cited by in Crossref: 74] [Cited by in F6Publishing: 74] [Article Influence: 4.4] [Reference Citation Analysis]
3 Salvaggio G, Campisi A, Lo Greco V, Cannella I, Meloni MF, Caruso G. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT. Abdom Imaging. 2010;35:447-453. [PMID: 19562414 DOI: 10.1007/s00261-009-9551-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
4 Huang X, Kojima-Yuasa A, Xu S, Kennedy DO, Hasuma T, Matsui-Yuasa I. Combination of Zizyphus jujuba and green tea extracts exerts excellent cytotoxic activity in HepG2 cells via reducing the expression of APRIL. Am J Chin Med 2009;37:169-79. [PMID: 19222120 DOI: 10.1142/S0192415X09006758] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
5 Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB (Oxford). 2005;7:42-49. [PMID: 18333160 DOI: 10.1080/13651820410024067] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 6.8] [Reference Citation Analysis]
6 Cheung YS, Chan HL, Wong J, Lee KF, Poon TC, Wong N, Lai PB. Elevated perioperative transaminase level predicts intrahepatic recurrence in hepatitis B-related hepatocellular carcinoma after curative hepatectomy. Asian J Surg. 2008;31:41-49. [PMID: 18490213 DOI: 10.1016/s1015-9584(08)60056-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
7 Wang WL, Zhu Y, Cheng JW, Li MX, Xia JM, Hao J, Yu L, Lv Y, Wu Z, Wang B. Major hepatectomy is safe for hepatocellular carcinoma in elderly patients with cirrhosis. Eur J Gastroenterol Hepatol. 2014;26:444-451. [PMID: 24463566 DOI: 10.1097/meg.0000000000000046] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
8 Ruzzenente A, Capra F, Pachera S, Iacono C, Piccirillo G, Lunardi M, Pistoso S, Valdegamberi A, D’onofrio M, Guglielmi A. Is Liver Resection Justified in Advanced Hepatocellular Carcinoma? Results of an Observational Study in 464 Patients. J Gastrointest Surg 2009;13:1313-20. [DOI: 10.1007/s11605-009-0903-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]